OBJECTIVE: Health of African Americans is seriously threatened by unremitting epidemics of diabetes and cardiovascular disease (CVD). However, the role of metabolic syndrome in the African-American population has not been investigated widely. This study examined the prevalence of metabolic syndrome and assessed its cross-sectional relationship to CVD in the Jackson Heart Study (JHS) cohort. RESEARCH DESIGN AND METHODS: A total of 5,302 participants aged >or=21 years who were recruited at baseline during 2000-2004 were analyzed for this study. Adjusted odds ratios (ORs) were estimated in a logistic regression analysis for coronary heart disease (CHD) and cerebrovascular disease (CBD) in those with and without coexisting metabolic syndrome. Diabetic participants were excluded. RESULTS: Among those aged 35-84 years, metabolic syndrome prevalence was 43.3% in women and 32.7% in men. Elevated blood pressure (70.4%), abdominal obesity (64.6%), and low HDL cholesterol (37.2%) were highly prevalent among those with metabolic syndrome. Prevalence rates for CVD, CHD, and CBD were 12.8, 8.7, and 5.8%, respectively. After adjustment for age and sex, metabolic syndrome was associated with increased age- and sex-adjusted ORs for CVD (OR 1.7 [95% CI 1.4-2.1]), CHD (1.7 [1.4-2.2]), and CBD (1.7 [1.3-2.3]) compared with those without CVD, CHD, or CBD. CONCLUSION: Metabolic syndrome prevalence in the JHS is among the highest reported for population-based cohorts worldwide and is significantly associated with increased ORs for CVD, CHD, and CBD. Abdominal obesity, increased blood pressure, and low HDL cholesterol (without triglyceride elevation) are surprisingly prominent. A high prevalence of low HDL emerges as a leading contributor to metabolic syndrome among African Americans in this large African-American cohort.
OBJECTIVE: Health of African Americans is seriously threatened by unremitting epidemics of diabetes and cardiovascular disease (CVD). However, the role of metabolic syndrome in the African-American population has not been investigated widely. This study examined the prevalence of metabolic syndrome and assessed its cross-sectional relationship to CVD in the Jackson Heart Study (JHS) cohort. RESEARCH DESIGN AND METHODS: A total of 5,302 participants aged >or=21 years who were recruited at baseline during 2000-2004 were analyzed for this study. Adjusted odds ratios (ORs) were estimated in a logistic regression analysis for coronary heart disease (CHD) and cerebrovascular disease (CBD) in those with and without coexisting metabolic syndrome. Diabeticparticipants were excluded. RESULTS: Among those aged 35-84 years, metabolic syndrome prevalence was 43.3% in women and 32.7% in men. Elevated blood pressure (70.4%), abdominal obesity (64.6%), and low HDL cholesterol (37.2%) were highly prevalent among those with metabolic syndrome. Prevalence rates for CVD, CHD, and CBD were 12.8, 8.7, and 5.8%, respectively. After adjustment for age and sex, metabolic syndrome was associated with increased age- and sex-adjusted ORs for CVD (OR 1.7 [95% CI 1.4-2.1]), CHD (1.7 [1.4-2.2]), and CBD (1.7 [1.3-2.3]) compared with those without CVD, CHD, or CBD. CONCLUSION:Metabolic syndrome prevalence in the JHS is among the highest reported for population-based cohorts worldwide and is significantly associated with increased ORs for CVD, CHD, and CBD. Abdominal obesity, increased blood pressure, and low HDL cholesterol (without triglyceride elevation) are surprisingly prominent. A high prevalence of low HDL emerges as a leading contributor to metabolic syndrome among African Americans in this large African-American cohort.
Authors: Hanna-Maaria Lakka; David E Laaksonen; Timo A Lakka; Leo K Niskanen; Esko Kumpusalo; Jaakko Tuomilehto; Jukka T Salonen Journal: JAMA Date: 2002-12-04 Impact factor: 56.272
Authors: Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant Journal: Arterioscler Thromb Vasc Biol Date: 2004-02 Impact factor: 8.311
Authors: James B Meigs; Peter W F Wilson; David M Nathan; Ralph B D'Agostino; Ken Williams; Steven M Haffner Journal: Diabetes Date: 2003-08 Impact factor: 9.461
Authors: Daniel W Jones; Lloyd E Chambless; Aaron R Folsom; Gerardo Heiss; Richard G Hutchinson; A Richey Sharrett; Moyses Szklo; Herman A Taylor Journal: Arch Intern Med Date: 2002 Dec 9-23
Authors: Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield Journal: Arch Intern Med Date: 2003-02-24
Authors: S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele Journal: Indian Heart J Date: 2000 Nov-Dec
Authors: C B Cook; D M Erdman; G J Ryan; K J Greenlund; W H Giles; D L Gallina; I M El-Kebbi; D C Ziemer; K L Ernst; V G Dunbar; L S Phillips Journal: Diabetes Care Date: 2000-03 Impact factor: 19.112
Authors: Sherita Hill Golden; Aaron R Folsom; Josef Coresh; A Richey Sharrett; Moyses Szklo; Frederick Brancati Journal: Diabetes Date: 2002-10 Impact factor: 9.461
Authors: Victor Y Fujimoto; Tarun Jain; Ruben Alvero; Lawrence M Nelson; William H Catherino; Moshood Olatinwo; Erica E Marsh; Diana Broomfield; Herman Taylor; Alicia Y Armstrong Journal: Fertil Steril Date: 2010-02-19 Impact factor: 7.329
Authors: Michelle I Cardel; Yi Guo; Mario Sims; Akilah Dulin; Darci Miller; Xiaofei Chi; Gregory Pavela; Mark D DeBoer; Matthew J Gurka Journal: Psychoneuroendocrinology Date: 2020-04-26 Impact factor: 4.905
Authors: Marino A Bruce; Bettina M Beech; Errol D Crook; Mario Sims; Derek M Griffith; Sean L Simpson; Jamy Ard; Keith C Norris Journal: J Investig Med Date: 2013-04 Impact factor: 2.895
Authors: Jiankang Liu; Caroline S Fox; Demarc Hickson; Daniel Sarpong; Lynette Ekunwe; Warren D May; Gregory W Hundley; J Jeffery Carr; Herman A Taylor Journal: Diabetes Care Date: 2010-04-22 Impact factor: 17.152